[Discontinuation of neuroleptic treatment in patients with schizophrenia].
Neuroleptic maintenance treatment in schizophrenia is a conflicting issue. There is no reliable criteria to identify patients for which neuroleptic withdrawal can be experienced. However, treatment discontinuation, whose risks can be limited, must be attempted for reasons such as the patient's wellbeing, longterm side-effects prevention and patient-doctor relationship management. Anyway, it can lead to more specific indications for drug maintenance.
Alagille
M
M
Service de Psychiatrie, Hôpital Paul Brousse, Villejuif.
Blondiaux
I
I
Ginestet
D
D
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D013997:Time Factors
D014150:Antipsychotic Agents
L'arrêt du traitement neuroleptique chez les patients schizophrènes.